Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Ryvu Therapeutics Presents New Clinical Data from RIVER-81 and POTAMI-61 Studies of ...

google.com·23w

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

google.com·23w

FDA fast-tracks Incyte drug for rare blood cancer (INCY:NASDAQ) | Seeking Alpha

google.com·23w

Incyte's First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted ...

google.com·23w

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted ...

google.com·23w

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of ...

google.com·23w

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted ...

google.com·23w

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted ...

google.com·23w

Incyte's First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted ...

google.com·23w

Incyte's First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted ...

google.com·23w

Rusfertide Provides Durable Hematocrit Control in <b>Polycythemia Vera</b> | Targeted Oncology

google.com·23w

Rusfertide Continues to Show Strong Results for <b>Polycythemia Vera</b> | OncLive

google.com·23w

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide ... - Nasdaq

google.com·23w

Disc Medicine, Inc. Presents Positive Initial Data from Rally-MF Phase 2 Trial in Patients with ...

google.com·23w

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of ...

google.com·23w

52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV | AJMC

google.com·23w

Prelude Therapeutics unveils new MPN data at 2025 ASH | PRLD Stock News

google.com·23w

Rusfertide Maintains Hematocrit Control Through 52 Weeks in VERIFY | HCPLive

google.com·23w

Protagonist And Takeda Report 52-Week Rusfertide Data In <b>Polycythemia Vera</b> - RTTNews

google.com·23w

Protagonist And Takeda Report 52-Week Rusfertide Data In <b>Polycythemia Vera</b>

google.com·23w

Log in to enable infinite scrolling